NDC 16729-267 – Docetaxel
Docetaxel Anhydrous 20 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC16729-267
Product details
- Brand name
- Docetaxel
- Generic name
- Docetaxel
- Labeler
- Accord Healthcare Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- NDA · NDA201195
- Marketed since
- May 30, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Docetaxel Anhydrous 20 mg/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 16729-267-63 | 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-63) / 1 mL in 1 VIAL, MULTI-DOSE | Oct 22, 2013 |
| 16729-267-64 | 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-64) / 4 mL in 1 VIAL, MULTI-DOSE | Aug 2, 2013 |
| 16729-267-65 | 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-65) / 8 mL in 1 VIAL, MULTI-DOSE | May 30, 2013 |
Other Docetaxel products
- 45963-734 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 45963-765 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 0143-9204 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Hikma Pharmaceuticals USA Inc.
- 0143-9205 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Hikma Pharmaceuticals USA Inc.
- 57884-3041 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 57884-3042 Docetaxel 80 mg/4mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 57884-3043 Docetaxel 160 mg/8mL · Injection, Solution, Concentrate · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- 71288-133 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-152 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 67457-781 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Mylan Institutional LLC
- 0955-1022 Docetaxel 160 mg/8mL · Injection, Solution, Concentrate · Sanofi-Aventis U.S. LLC
- 0955-1020 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Sanofi-Aventis U.S. LLC